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Empyema thoracis (ET) is defined as the collection of pus in the pleural cavity [1]. It is a life-threatening disease frequently encountered in pediatric patients. Over 2000 years 
ago, Hippocrates was the first to diagnose this disease by drainage 
of the pleural cavity [2]. It is most commonly caused due to 
staphylococci and less commonly due to Haemophilus influenzae. 
It may occasionally develop as a result of trauma, rupture of lung 
abscess, or a complication of primary tuberculosis (TB).
ET in children is usually caused secondary to bacterial 
pneumonia. The peak incidence of pneumonia in childhood is in 
those under 5 years of age, and a rise in pneumonia is responsible 
for a major proportion of hospital admission in children [3]. 
About 0.6% of pneumonia leads to the development of empyema 
thoracis [4,5]. In the recent antimicrobial era, the incidence of 
this disease is still increasing in both developed and developing 
countries and is a real burden to the society. Day by day, the high 
morbidity and mortality rate among children are increasing due to 
empyema. The cause of this may be due to poverty, negligence, 
malnutrition, or multidrug resistance [6-8]. Hence, the present 
study was carried out to evaluate the age-sex profile, etiology, 
clinical features, and predisposing factors of ET in a tertiary care 
center of Western Odisha.
MATERIALS AND METHODS
A cross-sectional study was conducted in the department of 
pediatrics of a tertiary care center in Western Odisha region from 
January 2017 to December 2017. The study was approved by 
the Institutional Ethical Committee. Informed written consent 
was obtained from parents of all subjects before enrolment in 
the study. A convenient sample size of 80 was taken. Children 
aged 0–14 years, diagnosed as ET, and admitted in the pediatrics 
department during the study period were included. Patients having 
a history of congenital pulmonary or cardiac diseases, post-
surgical, and post-traumatic cases of empyema were excluded 
from the study.
After inclusion, a detailed history including demographical 
data, clinical examinations, and thorough investigations 
(hematological, biochemical, and radiological) was done as per 
pro forma prepared for the study. Pleural fluid was collected by 
thoracocentesis and examined for cultural sensitivity.
Data were analyzed using the SPSS software version 24.0 
(Statistical Package for the Social Sciences, IBM Inc., New York). 
Results were expressed in terms of mean, standard deviations, 
and percentage.
ABSTRACT
Background: Empyema thoracis (ET) is a life-threatening disease often encountered in pediatric patients. In spite of all modern 
sophistication of medical sciences, this disease is chargeable for a high proportion of hospital admission and continues to require 
an important tool against them. Objective: The objective of this study is to evaluate the age-sex profile, predisposing factors, 
etiology, seasonal variation, and clinical manifestations of ET in children. Methods: A cross-sectional study was conducted in 
the department of pediatrics in Western Odisha. A total of 80 children, aged 0–14 years and diagnosed as ET, were enrolled in 
the study. After inclusion, a detailed history including demographical data, clinical examinations, and thorough investigations 
(hematological, biochemical, and radiological) was done as per pro forma prepared for the study. Pleural fluid was collected by 
thoracocentesis and examined for cultural sensitivity. Results: Most of the cases belonged to the age group of 0–5 years (60%), and 
male-female ratio was 3:2. Of 80, 50 (72.5%) patients were malnourished. The most common symptoms in all patients were fever 
(100%) and cough (90%). Intercostal tenderness (100%) was the most common clinical sign. Staphylococcus aureus (60%) was 
the predominant causative organism. Conclusions: The prognosis of childhood empyema depends on the age, nutritional status of 
the child, and bacterial agent causing empyema. Earlier diagnosis and adequate treatment of potential predisposing factors favor 
the good prognosis.
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RESULTS
In the present study, we found that most of the cases were below 
the age of 5 years (48) and a majority of them were males (60%) 
child as shown in Table 1. We also observed that various grades 
of malnutrition were found in most of the patients, i.e., 27.5% 
(22) Grade-I, 40% (32) Grade-II, 2.5% (2) Grade-III, 2.5% (2) 
Grade-IV, and 27.5% (22) patients were normal.
Various signs and symptoms of the disease present in 
children were fever, cough, breathlessness, and chest pain as 
shown in Table 2. Fever (100%) followed by a cough (90%) and 
breathlessness (60%) were the most common symptoms present 
in children, whereas intercostal tenderness (100%) followed by 
tachypnea (87.5%) and diminished chest movement (82.5%) 
were the most common signs.
In this study, the radiological findings reported were 
pyopneumothorax (65%, n=56), loculated empyema (17.5%, 
n=10), consolidation (10%, n=8), and pleural thickening (7.5%, 
n=6). We also observed that right-sided pleura was involved in 
55% (n=44) of cases, left-sided pleura was involved in 42.5% 
(n=34) of cases, and 2.5 % (n=2) cases showed bilateral pleural 
involvement. Fig. 1 shows the X-ray findings of right lower lobe 
involvement. These findings were again confirmed by doing 
ultrasonography and computed tomography (CT) of the chest, 
and pleural thickening was assessed.
While doing microbiological analysis, the culture sensitivity 
pattern of pleural pus showed that 60% of subjects were affected 
by Staphylococcus aureus, 27.5% by Streptococcus, 7.5% by 
Klebsiella pneumoniae, 2.5% by H. influenza, and 2.5% by 
Mycobacterium tuberculosis as shown in Table 3. In this study, 
S. aureus was the predominant organism responsible for ET. Most 
of the cases (46%) appeared in the second quarter (April–June) of 
the year 2017.
DISCUSSION
The name “Empyema” comes from the Greek word empyein 
meaning pus producing (suppurate). In pediatrics population, 
ET most frequently occurs secondary to bacterial pneumonia 
and less commonly from pneumococci or H. influenza. It may 
occasionally develop as a result of trauma, rupture of lung abscess, 
or a complication of primary pulmonary TB. Other predisposing 
factors are poverty, immune deficiency which may be due to 
inadequate vaccination, poor orodental hygiene, and aspiration 
syndrome.
In this study, most of the ET patients were below the age of 
5 years. This result was in accordance with the study of Geha 
et al. [9]. A study done in 2016 by Dalavi et al. reported that 
52.5% of empyema patients were below 5 years of age [10]. 
We also observed that majority of patients were males (48 male 
children of 80 cases). Another study conducted by Saleem et al. 
in 2014 also reported that males outnumbered the females in the 
development of this disease [11].
Another most important finding of this study was that the 
maximum number of patients was suffering from malnutrition. 
In a study by Goyal et al., similar findings were observed, but 
they also found anemia along with malnutrition in all cases [12]. 
Magnet et al. reported that the majority of cases suffering from 
this disease belonged to low socioeconomic status [13]. Since 
malnutrition and socioeconomic status have got definite a relation 
to pulmonary infection, more number of children suffering from 
this disease were either malnourished or of low socioeconomic 
status as proved in these studies.
The most common clinical symptoms found in our study 
were fever (100%), cough (90%), and intercostal tenderness 
(100%) as a most common sign. A similar result of the presence 
of fever, cough, and breathlessness in all patients was reported in 
a previous study by Dalavi et al. [10]. We found right-sided chest 
involvement in 55% of cases. A study was done by Stephen and 
Kilman also reported similar results [14]. These studies proved 
that lung infections are common in the right side than the left 
side.
While doing a microbiological analysis of pleural pus, we 
observed that S. aureus was the most common causative organism; 
the second most common was streptococcus. Worldwide, several 
studies have been reported stating the association of these two 
organisms in the development of ET in children [5,15,16]. 
A previous study conducted by Dalavi et al. also observed similar 
results in their study [10].
In this study, an attempt was made to document some important 
predisposing factors and clinical features of empyema in children. 
However, we had not considered the treatment modalities and 
outcome of this disease which would be of utility. Moreover, the 
sample size was small, so further studies on larger sample size is 
essential for better results.Figure 1: X-ray of right lower lobe of the lung in empyema
Table 1: Age and sex distribution of the study participants (n=80)
Age (years) Sex (%)
Males Females
0–5 32.5 (n=26) 27 (n=22)
5–10 17.5 (n=14) 12.5 (n=10)
10–14 10 (n=8) 0
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CONCLUSION
On the basis of the results of this study, it can be concluded that 
empyema in children depends on the age, nutritional status, 
and causative bacteriological agents. Any child presenting with 
the respiratory problem should be examined thoroughly for 
the presence of empyema, especially in cases of pneumonia. 
Prevention of potential predisposing factors and early diagnosis 
favors good prognosis for empyema.
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Table 2: Clinical symptoms and signs of empyema
Symptoms n (%) Signs n (%)
Fever 80 (100) Intercostal tenderness 80 (100)
Cough 72 (90) Tachypnea 70 (87.5)
Breathlessness 52 (65) Diminished chest movement 66 (82.5)
Chest pain 32 (40) Mediastinal shift 60 (75)
Pain abdomen 12 (15) Cyanosis 4 (5)
Abdominal distension 2 (2.5)
Vomiting 2 (2.5)
Excessive crying 2 (2.5)
Loss of appetite 2 (2.5)
Swelling of leg and face 2 (2.5)
Pain in limbs 2 (2.5)
Table 3: Culture and sensitivity pattern of pleural pus in empyema 
patients
Causative organisms (n) %
S. aureus (n=48) 60
Streptococcus (n=22) 27.5
K. pneumoniae (n=6) 7.5
H. influenzae (n=2) 2.5
M. TB (n=2) 2.5
S. aureus: Staphylococcus aureus, K. pneumoniae: Klebsiella pneumoniae, 
H. influenza: Haemophilus influenza, TB: Tuberculosis
